vs
Lantheus Holdings, Inc.（LNTH）とPROGRESS SOFTWARE CORP（PRGS）の財務データ比較。上の社名をクリックして会社を切り替えられます
Lantheus Holdings, Inc.の直近四半期売上が大きい（$406.8M vs $252.7M、PROGRESS SOFTWARE CORPの約1.6倍）。Lantheus Holdings, Inc.の純利益率が高く（13.3% vs 10.2%、差は3.1%）。PROGRESS SOFTWARE CORPの前年同期比売上増加率が高い（17.5% vs 4.0%）。Lantheus Holdings, Inc.の直近四半期フリーキャッシュフローが多い（$81.4M vs $59.9M）。過去8四半期でPROGRESS SOFTWARE CORPの売上複合成長率が高い（17.0% vs 4.9%）
ランティウス・ホールディングスはグローバルな医療企業で、革新的な診断用造影剤や関連ソリューションの開発・製造・販売を事業の核としています。製品は腫瘍学、循環器学、泌尿器学などの分野に対応し、北米を中心に世界の主要市場で事業を展開しています。
プログレスソフトウェアコーポレーションは、アプリケーション開発プラットフォーム、データ接続ツール、デジタルエクスペリエンスソリューションなどの企業向けソフトウェアを開発・販売しています。金融、医療、製造、小売など世界中の多様な業界の顧客にサービスを提供し、業務効率化と高性能業務アプリの構築を支援しています。
LNTH vs PRGS — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $406.8M | $252.7M |
| 純利益 | $54.1M | $25.7M |
| 粗利率 | 59.2% | 81.6% |
| 営業利益率 | 19.0% | 15.2% |
| 純利益率 | 13.3% | 10.2% |
| 売上前年比 | 4.0% | 17.5% |
| 純利益前年比 | 558.8% | 2144.6% |
| EPS（希薄化後） | $0.86 | $0.59 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $406.8M | $252.7M | ||
| Q3 25 | $384.0M | $249.8M | ||
| Q2 25 | $378.0M | $237.4M | ||
| Q1 25 | $372.8M | $238.0M | ||
| Q4 24 | $391.1M | $215.0M | ||
| Q3 24 | $378.7M | $178.7M | ||
| Q2 24 | $394.1M | $175.1M | ||
| Q1 24 | $370.0M | $184.7M |
| Q4 25 | $54.1M | $25.7M | ||
| Q3 25 | $27.8M | $19.4M | ||
| Q2 25 | $78.8M | $17.0M | ||
| Q1 25 | $72.9M | $10.9M | ||
| Q4 24 | $-11.8M | $1.1M | ||
| Q3 24 | $131.1M | $28.5M | ||
| Q2 24 | $62.1M | $16.2M | ||
| Q1 24 | $131.1M | $22.6M |
| Q4 25 | 59.2% | 81.6% | ||
| Q3 25 | 57.9% | 81.0% | ||
| Q2 25 | 63.8% | 80.1% | ||
| Q1 25 | 63.8% | 80.6% | ||
| Q4 24 | 63.5% | 83.0% | ||
| Q3 24 | 63.9% | 83.7% | ||
| Q2 24 | 64.9% | 81.7% | ||
| Q1 24 | 65.4% | 82.2% |
| Q4 25 | 19.0% | 15.2% | ||
| Q3 25 | 11.4% | 17.6% | ||
| Q2 25 | 23.3% | 16.3% | ||
| Q1 25 | 27.4% | 13.6% | ||
| Q4 24 | 29.1% | 10.0% | ||
| Q3 24 | 35.3% | 22.6% | ||
| Q2 24 | 26.1% | 15.5% | ||
| Q1 24 | 28.8% | 19.0% |
| Q4 25 | 13.3% | 10.2% | ||
| Q3 25 | 7.2% | 7.8% | ||
| Q2 25 | 20.8% | 7.2% | ||
| Q1 25 | 19.6% | 4.6% | ||
| Q4 24 | -3.0% | 0.5% | ||
| Q3 24 | 34.6% | 15.9% | ||
| Q2 24 | 15.8% | 9.2% | ||
| Q1 24 | 35.4% | 12.3% |
| Q4 25 | $0.86 | $0.59 | ||
| Q3 25 | $0.41 | $0.44 | ||
| Q2 25 | $1.12 | $0.39 | ||
| Q1 25 | $1.02 | $0.24 | ||
| Q4 24 | $-0.18 | $0.01 | ||
| Q3 24 | $1.79 | $0.65 | ||
| Q2 24 | $0.88 | $0.37 | ||
| Q1 24 | $1.87 | $0.51 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $359.1M | $94.8M |
| 総負債低いほど良い | $568.7M | $1.4B |
| 株主資本純資産 | $1.1B | $478.3M |
| 総資産 | $2.2B | $2.5B |
| 負債/資本比率低いほどレバレッジが低い | 0.52× | 2.93× |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $359.1M | $94.8M | ||
| Q3 25 | $382.0M | $99.0M | ||
| Q2 25 | $695.6M | $102.0M | ||
| Q1 25 | $938.5M | $124.2M | ||
| Q4 24 | $912.8M | $118.1M | ||
| Q3 24 | $866.4M | $232.7M | ||
| Q2 24 | $757.0M | $190.4M | ||
| Q1 24 | $718.3M | $133.2M |
| Q4 25 | $568.7M | $1.4B | ||
| Q3 25 | $567.9M | $1.4B | ||
| Q2 25 | $566.8M | $1.5B | ||
| Q1 25 | $566.1M | $1.5B | ||
| Q4 24 | $565.3M | $1.5B | ||
| Q3 24 | $613.0K | — | ||
| Q2 24 | $563.2M | — | ||
| Q1 24 | $562.5M | — |
| Q4 25 | $1.1B | $478.3M | ||
| Q3 25 | $1.1B | $477.7M | ||
| Q2 25 | $1.2B | $452.7M | ||
| Q1 25 | $1.2B | $431.8M | ||
| Q4 24 | $1.1B | $438.8M | ||
| Q3 24 | $1.2B | $425.6M | ||
| Q2 24 | $1.0B | $401.7M | ||
| Q1 24 | $945.5M | $461.7M |
| Q4 25 | $2.2B | $2.5B | ||
| Q3 25 | $2.3B | $2.4B | ||
| Q2 25 | $2.1B | $2.4B | ||
| Q1 25 | $2.1B | $2.5B | ||
| Q4 24 | $2.0B | $2.5B | ||
| Q3 24 | $2.0B | $1.6B | ||
| Q2 24 | $1.9B | $1.6B | ||
| Q1 24 | $1.8B | $1.5B |
| Q4 25 | 0.52× | 2.93× | ||
| Q3 25 | 0.51× | 2.97× | ||
| Q2 25 | 0.49× | 3.22× | ||
| Q1 25 | 0.49× | 3.50× | ||
| Q4 24 | 0.52× | 3.48× | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | 0.55× | — | ||
| Q1 24 | 0.59× | — |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $90.2M | $62.8M |
| フリーキャッシュフロー営業CF - 設備投資 | $81.4M | $59.9M |
| FCFマージンFCF / 売上 | 20.0% | 23.7% |
| 設備投資強度設備投資 / 売上 | 2.2% | 1.1% |
| キャッシュ転換率営業CF / 純利益 | 1.67× | 2.44× |
| 直近12ヶ月FCF直近4四半期 | $354.1M | $229.5M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $90.2M | $62.8M | ||
| Q3 25 | $105.3M | $73.4M | ||
| Q2 25 | $87.1M | $30.0M | ||
| Q1 25 | $107.6M | $68.9M | ||
| Q4 24 | $157.7M | $19.7M | ||
| Q3 24 | $175.1M | $57.7M | ||
| Q2 24 | $84.7M | $63.7M | ||
| Q1 24 | $127.2M | $70.5M |
| Q4 25 | $81.4M | $59.9M | ||
| Q3 25 | $94.7M | $72.4M | ||
| Q2 25 | $79.1M | $29.5M | ||
| Q1 25 | $98.8M | $67.7M | ||
| Q4 24 | $141.4M | $16.8M | ||
| Q3 24 | $159.3M | $56.6M | ||
| Q2 24 | $73.5M | $62.7M | ||
| Q1 24 | $119.0M | $70.2M |
| Q4 25 | 20.0% | 23.7% | ||
| Q3 25 | 24.7% | 29.0% | ||
| Q2 25 | 20.9% | 12.4% | ||
| Q1 25 | 26.5% | 28.4% | ||
| Q4 24 | 36.1% | 7.8% | ||
| Q3 24 | 42.0% | 31.7% | ||
| Q2 24 | 18.7% | 35.8% | ||
| Q1 24 | 32.2% | 38.0% |
| Q4 25 | 2.2% | 1.1% | ||
| Q3 25 | 2.8% | 0.4% | ||
| Q2 25 | 2.1% | 0.2% | ||
| Q1 25 | 2.3% | 0.5% | ||
| Q4 24 | 4.2% | 1.3% | ||
| Q3 24 | 4.2% | 0.6% | ||
| Q2 24 | 2.8% | 0.5% | ||
| Q1 24 | 2.2% | 0.2% |
| Q4 25 | 1.67× | 2.44× | ||
| Q3 25 | 3.79× | 3.78× | ||
| Q2 25 | 1.11× | 1.76× | ||
| Q1 25 | 1.47× | 6.30× | ||
| Q4 24 | — | 17.13× | ||
| Q3 24 | 1.34× | 2.03× | ||
| Q2 24 | 1.36× | 3.93× | ||
| Q1 24 | 0.97× | 3.11× |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
LNTH
| Radiopharmaceutical Oncology | $240.2M | 59% |
| Definity | $85.3M | 21% |
| Strategic Partnerships And Other | $23.3M | 6% |
| Techne Lite | $21.0M | 5% |
| Licenseand Royalty Revenues | $17.4M | 4% |
| Other | $13.6M | 3% |
| Other Precision Diagnostics | $5.9M | 1% |
PRGS
| Maintenanceand Services | $187.5M | 74% |
| Share File Acquisition | $67.5M | 27% |
